What is the Return on Assets (ROA) of Genmab A/S this year?
The Return on Assets (ROA) of Genmab A/S is 0.12 undefined this year.
Genmab A/S ROA 2025
Genmab A/S ROA
0.12
Ticker
GMAB.CO
ISIN
DK0010272202
WKN
565131
In 2025, Genmab A/S's return on assets (ROA) was 0.12, a -31.87% increase from the 0.18 ROA in the previous year.
Genmab A/S Aktienanalyse
What does Genmab A/S do?
Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Genmab A/S's Return on Assets (ROA)
Genmab A/S's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Genmab A/S's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Genmab A/S's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Genmab A/S’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Genmab A/S stock
What was the ROA of Genmab A/S compared to the previous year?
The ROA of Genmab A/S has increased by -31.87% compared to the previous year.
What consequences do high ROA have for investors of Genmab A/S?
A high ROA is advantageous for investors of Genmab A/S, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Genmab A/S?
A low ROA can be unfavorable for investors of Genmab A/S as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Genmab A/S affect the company?
An increase in ROA of Genmab A/S can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Genmab A/S impact the company?
A reduction in the ROA of Genmab A/S can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Genmab A/S?
Some factors that can influence the ROA of Genmab A/S include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Genmab A/S important for investors?
The ROA of Genmab A/S is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Genmab A/S take to improve ROA?
To improve ROA, Genmab A/S can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Genmab A/S pay?
Over the past 12 months, Genmab A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genmab A/S is expected to pay a dividend of 0 DKK.
What is the dividend yield of Genmab A/S?
The current dividend yield of Genmab A/S is .
When does Genmab A/S pay dividends?
Genmab A/S pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genmab A/S?
Genmab A/S paid dividends every year for the past 0 years.
What is the dividend of Genmab A/S?
For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genmab A/S located?
Genmab A/S is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genmab A/S kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genmab A/S from 2/27/2025 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 2/27/2025.
When did Genmab A/S pay the last dividend?
The last dividend was paid out on 2/27/2025.
What was the dividend of Genmab A/S in the year 2024?
In the year 2024, Genmab A/S distributed 0 DKK as dividends.
In which currency does Genmab A/S pay out the dividend?
The dividends of Genmab A/S are distributed in DKK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Genmab A/S stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Genmab A/S
Our stock analysis for Genmab A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genmab A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
